✦ LIBER ✦

Daclatasvir: a team player rather than a prima donna in the treatment of hepatitis C

✍ Scribed by Aghemo, Alessio; De Francesco, Raffaele

Book ID: 126277896
Publisher: BMJ Publishing Group
Year: 2014
Tongue: English
Weight: 190 KB
Volume: 64
Category: Article
ISSN: 0017-5749
DOI: 10.1136/gutjnl-2014-307958

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacological exposure to ribavirin: A

Pharmacological exposure to ribavirin: A key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment

✍ Véronique Loustaud-Ratti; Paul Carrier; Annick Rousseau; Marianne Maynard; Gérar 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Racial differences in hepatitis C treatm

Racial differences in hepatitis C treatment eligibility

✍ Michael T. Melia; Andrew J. Muir; Jonathan McCone; Mitchell L. Shiffman; John W. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB

Black Americans are disproportionally infected with hepatitis C virus (HCV) and are less likely than whites to respond to treatment with peginterferon (PEG-IFN) plus ribavirin (RBV). The impact of race on HCV treatment eligibility is unknown. We therefore performed a retrospective analysis of a phas

1187 IFN STIMULATED GENE EXPRESSION IN T

1187 IFN STIMULATED GENE EXPRESSION IN THE LIVER IS A BETTER PREDICTOR OF TREATMENT RESPONSE IN CHRONIC HEPATITIS C THAN THE IL28B (IFNλ3) GENOTYPE

✍ Dill, M.T.; Duong, F.H.T.; Vogt, J.E.; Bibert, S.; Bochud, P.-Y.; Terracciano, L 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 55 KB

CS4-5 IFN stimulated gene expression in

CS4-5 IFN stimulated gene expression in the liver is a better predictor of treatment response in chronic hepatitis C than the IL28B (IFNλ3) genotype

✍ Michael T. Dill; Francois H.T. Duong; Julia E. Vogt; Stéphanie Bibert; Pierre-Yv 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Analysis of sustained responders in the

Analysis of sustained responders in the treatment of chronic hepatitis C with interferon: viral clearance is more associated with genotype III or IV (2a, 2b) than genotype II (1b)

✍ Kouichirou Iwata; Masashi Ihori; Keiji Mitamura; Fumiaki Ikegami; Koichi Kanai 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 243 KB